Cargando…
Targeting Amyloidogenic Processing of APP in Alzheimer’s Disease
Alzheimer’s disease (AD) is the most common type of senile dementia, characterized by neurofibrillary tangle and amyloid plaque in brain pathology. Major efforts in AD drug were devoted to the interference with the production and accumulation of amyloid-β peptide (Aβ), which plays a causal role in t...
Autores principales: | Zhao, Jing, Liu, Xinyue, Xia, Weiming, Zhang, Yingkai, Wang, Chunyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418514/ https://www.ncbi.nlm.nih.gov/pubmed/32848600 http://dx.doi.org/10.3389/fnmol.2020.00137 |
Ejemplares similares
-
Connecting Alzheimer’s Disease With Diabetes Mellitus Through Amyloidogenic Evolvability
por: Ho, Gilbert, et al.
Publicado: (2020) -
Comparison of Cerebrospinal Fluid Amyloidogenic Nanoplaques With Core Biomarkers of Alzheimer’s Disease
por: Aksnes, Mari, et al.
Publicado: (2021) -
miR-143-3p Inhibits Aberrant Tau Phosphorylation and Amyloidogenic Processing of APP by Directly Targeting DAPK1 in Alzheimer’s Disease
por: Wang, Long, et al.
Publicado: (2022) -
Involvement of Receptor Tyrosine Kinase Tyro3 in Amyloidogenic APP Processing and β-Amyloid Deposition in Alzheimer's Disease Models
por: Zheng, Yan, et al.
Publicado: (2012) -
Tyr(682) in the Intracellular Domain of APP Regulates Amyloidogenic APP Processing In Vivo
por: Barbagallo, Alessia P. M., et al.
Publicado: (2010)